| 1 |
Ghasemi Darestani N, Gilmanova AI, Al-Gazally ME, Zekiy AO, Ansari MJ, Zabibah RS, Jawad MA, Al-Shalah SAJ, Rizaev JA, Alnassar YS, Mohammed NM, Mustafa YF, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal 2023;21:43. [PMID: 36829187 DOI: 10.1186/s12964-022-01012-0] [Reference Citation Analysis]
|
| 2 |
Wu Z, Bian Y, Chu T, Wang Y, Man S, Song Y, Wang Z. The role of angiogenesis in melanoma: Clinical treatments and future expectations. Front Pharmacol 2022;13:1028647. [PMID: 36588679 DOI: 10.3389/fphar.2022.1028647] [Reference Citation Analysis]
|
| 3 |
Chen X, Wang Y, Liu H, Zhang J, Wang J, Jin X, Ma Y. CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinβ1. BMC Cancer 2022;22:1200. [PMID: 36419008 DOI: 10.1186/s12885-022-10318-8] [Reference Citation Analysis]
|
| 4 |
Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev 2022;185:114300. [PMID: 35447165 DOI: 10.1016/j.addr.2022.114300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Keshavarz M, Mohammad Miri S, Behboudi E, Arjeini Y, Dianat-Moghadam H, Ghaemi A. Oncolytic virus delivery modulated immune responses toward cancer therapy: Challenges and perspectives. Int Immunopharmacol 2022;108:108882. [PMID: 35623296 DOI: 10.1016/j.intimp.2022.108882] [Reference Citation Analysis]
|
| 6 |
Zhang Q, Li Y, Fender P, Yu B, Feng L, Chen L, Yu X. Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications. Front Microbiol 2022;13:869059. [DOI: 10.3389/fmicb.2022.869059] [Reference Citation Analysis]
|
| 7 |
Attia N, Mashal M, Pemminati S, Omole A, Edmondson C, Jones W, Priyadarshini P, Mughal T, Aziz P, Zenick B, Perez A, Lacken M. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies. Cells 2021;11:116. [PMID: 35011678 DOI: 10.3390/cells11010116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Wang Y, Sheng J, Chai J, Zhu C, Li X, Yang W, Cui R, Ge T. Filamentous Bacteriophage-A Powerful Carrier for Glioma Therapy. Front Immunol 2021;12:729336. [PMID: 34566987 DOI: 10.3389/fimmu.2021.729336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
